Cargando…

Cystic Fibrosis Respiratory Microbiology Monitoring during a Global Pandemic: Lessons Learned from a Shift to Telehealth

Detalles Bibliográficos
Autores principales:	Franciosi, Alessandro N., Wilcox, Pearce G., Quon, Bradley S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937220/ https://www.ncbi.nlm.nih.gov/pubmed/34406918 http://dx.doi.org/10.1513/AnnalsATS.202101-087RL

Ejemplares similares

TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)()
por: Franciosi, Alessandro N, et al.
Publicado: (2021)

Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis
por: Prieto, Miguel D., et al.
Publicado: (2023)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
por: Dagenais, Renée VE., et al.
Publicado: (2022)

The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020)

Experience to date with CFTR modulators during pregnancy and breastfeeding in the British Columbia Cystic Fibrosis clinic
por: Goodwin, Jodi, et al.
Publicado: (2022)

Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre
por: Roberts, James M., et al.
Publicado: (2016)

Diagnostic agreement among experts assessing adults presenting with possible cystic fibrosis: need for improvement and implications for patient care
por: Franciosi, Alessandro N., et al.
Publicado: (2022)

Patient knowledge and pulmonary medication adherence in adult patients with cystic fibrosis
por: Lin, Ann Hsu-An, et al.
Publicado: (2017)

Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes
por: Lam, Grace Y., et al.
Publicado: (2021)

Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Quon, Bradley S., et al.
Publicado: (2014)

Optic Disc Swelling and Vision Loss in a Patient with Cystic Fibrosis and Diabetes
por: Iosfina, Ioulia, et al.
Publicado: (2013)

Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations
por: Sharma, Ashutosh, et al.
Publicado: (2017)

Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016)

The microbiology associated with cystic fibrosis
por: McGowan, Karin L.
Publicado: (1988)

Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease
por: Prieto, Miguel Dario, et al.
Publicado: (2022)

Short-term effects of Lumacaftor/Ivacaftor (Orkambi™) on exertional symptoms, exercise performance, and ventilatory responses in adults with cystic fibrosis
por: Quon, Bradley S., et al.
Publicado: (2020)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Falling through the Cracks—The Impact of Care Gaps on Lung Function Loss in Cystic Fibrosis
por: Love, Allison J., et al.
Publicado: (2023)

The impact of telehealth based care on paediatric cystic fibrosis outcomes
por: Rimbaldo, Kristene, et al.
Publicado: (2023)

Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices
por: Caballero, Juan de Dios, et al.
Publicado: (2014)

Infections in Patients with Cystic Fibrosis: Diagnostic Microbiology Update
por: Gilligan, Peter H.
Publicado: (2014)

Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic
por: Hasan, Sana, et al.
Publicado: (2021)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
por: Dagenais, Renée V. E., et al.
Publicado: (2020)

IMPACT OF PORTABLE SPIROMETERS IN DELIVERY OF CYSTIC FIBROSIS CARE VIA TELEHEALTH
por: LO, KAREN, et al.
Publicado: (2021)

Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
por: Lambiase, Antonietta, et al.
Publicado: (2006)

Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review
por: Nguyen, Anna-Lisa V., et al.
Publicado: (2022)

Worsening pulmonary outcomes during sex reassignment therapy in a transgender female with cystic fibrosis (CF) and asthma/allergic bronchopulmonary aspergillosis: a case report
por: Lam, G. Y., et al.
Publicado: (2020)

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis
por: Qvist, Tavs, et al.
Publicado: (2014)

333: Perceptions of telehealth of patients with cystic fibrosis and their caregivers during the COVID-19 pandemic in Australia
por: Ruseckaite, R., et al.
Publicado: (2021)

Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs()
por: Gifford, Alex H., et al.
Publicado: (2021)

Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1
por: Saferali, Aabida, et al.
Publicado: (2020)

Development of an Interdisciplinary Telehealth Care Model in a Pediatric Cystic Fibrosis Center
por: Enochs, Catherine, et al.
Publicado: (2021)

Lessons learned from metabolomics in cystic fibrosis
por: Muhlebach, Marianne S., et al.
Publicado: (2015)

Factors associated with frequent high-cost individuals with cystic fibrosis and their healthcare utilization and cost patterns
por: Desai, Sameer, et al.
Publicado: (2023)

Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients
por: Al-momani, H., et al.
Publicado: (2016)

Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem
por: Riquena, Barbara, et al.
Publicado: (2019)

A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis
por: Habib, Al-Rahim R., et al.
Publicado: (2019)

Evaluating barriers to and promotors of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs (Commentary)()
por: Ranganathan, Sarath C.
Publicado: (2021)

Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic
por: Perkins, Ryan C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dk89rh3kq3fh9fbr94p1491qtp